GROUP ONE TRADING, L.P. - CARDIOME PHARMA CORP ownership

CARDIOME PHARMA CORP's ticker is CRME and the CUSIP is 14159U301. A total of 27 filers reported holding CARDIOME PHARMA CORP in Q4 2013. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
GROUP ONE TRADING, L.P. ownership history of CARDIOME PHARMA CORP
ValueSharesWeighting
Q1 2018$2,000
+100.0%
9170.0%0.00%
Q4 2017$1,000
-50.0%
9170.0%0.00%
Q3 2017$2,000
-94.1%
917
-87.7%
0.00%
Q2 2017$34,000
-52.8%
7,441
-68.8%
0.00%
-100.0%
Q1 2017$72,000
+148.3%
23,870
+123.7%
0.00%
Q4 2016$29,000
-84.0%
10,670
-81.5%
0.00%
-100.0%
Q3 2016$181,000
+4425.0%
57,770
+8358.3%
0.00%
Q2 2016$4,000
+33.3%
6830.0%0.00%
Q1 2016$3,000
-86.4%
683
-74.9%
0.00%
Q4 2015$22,000
-79.0%
2,722
-78.0%
0.00%
-100.0%
Q3 2015$105,000
-85.2%
12,397
-83.5%
0.00%
-90.0%
Q2 2015$708,000
+237.1%
75,222
+232.0%
0.01%
+233.3%
Q1 2015$210,000
+3400.0%
22,656
+3246.5%
0.00%
Q4 2014$6,000
-90.0%
677
-90.0%
0.00%
-100.0%
Q3 2014$60,000
-78.5%
6,741
-81.0%
0.00%
-75.0%
Q2 2014$279,000
+54.1%
35,421
+54.6%
0.00%
+33.3%
Q1 2014$181,000
-47.1%
22,905
-58.2%
0.00%
-40.0%
Q4 2013$342,000
+362.2%
54,815
+160.2%
0.01%
+400.0%
Q3 2013$74,00021,0670.00%
Other shareholders
CARDIOME PHARMA CORP shareholders Q4 2013
NameSharesValueWeighting ↓
Stonepine Capital Management, LLC 3,241,550$7,520,0004.03%
Tamarack Advisers, LP 1,875,000$4,350,0002.07%
CLOUGH CAPITAL PARTNERS L P 2,075,663$4,816,0000.46%
Rock Springs Capital Management LP 1,200,000$2,784,0000.12%
WESTFIELD CAPITAL MANAGEMENT CO LP 4,192,034$9,726,0000.08%
PUTNAM INVESTMENTS LLC 3,092,133$7,174,0000.02%
Renaissance Technologies 528,913$1,227,0000.00%
SCOTIA CAPITAL INC. 19,120$44,0000.00%
PNC FINANCIAL SERVICES GROUP, INC. 51,200$118,0000.00%
WELLS FARGO & COMPANY/MN 700$2,0000.00%
View complete list of CARDIOME PHARMA CORP shareholders